Fate Therapeutics
(FATE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,101 | 54,036 | 9,087 | 0 | N/A |
| TOTAL | $49,861 | $54,651 | $9,793 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,200 | 810 | 1,161 | 0 | N/A |
| Other Non-Current Assets | 122 | 122 | 122 | 0 | 0 |
| TOTAL | $1,322 | $932 | $1,283 | $N/A | $N/A |
| Total Assets | $51,183 | $55,583 | $11,076 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,535 | 1,732 | 1,941 | 0 | N/A |
| Accounts payable and accrued liabilities | 645 | 682 | 1,228 | 0 | 0 |
| Accrued Expenses | 2,260 | 2,039 | 1,040 | 0 | N/A |
| Other current liabilities | 130 | 147 | 578 | 0 | N/A |
| TOTAL | $4,570 | $4,600 | $4,850 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,073 | N/A | 1,732 | 0 | N/A |
| Deferred Revenues | N/A | N/A | 63 | N/A | N/A |
| Other Non-Current Liabilities | 200 | 135 | 793 | 0 | 0 |
| TOTAL | $18,273 | $135 | $2,525 | $N/A | $N/A |
| Total Liabilities | $22,843 | $4,735 | $7,375 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,637 | 20,436 | N/A | N/A | N/A |
| Common Shares | 21 | 20 | 1 | 0 | N/A |
| Retained earnings | -112,392 | -86,509 | -65,615 | 0 | N/A |
| Other shareholders' equity | 0 | 0 | 56,526 | 0 | 0 |
| TOTAL | $28,340 | $50,848 | $3,701 | $0 | $N/A |
| Total Liabilities And Equity | $51,183 | $55,583 | $11,076 | $0 | $0 |